CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CervoMed Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CervoMed Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Boger Joshua S | Director, 10% Owner | 1,795,865Indirect | Jun 15, 2026 | 2 |
| Alam John J | CEO & President | 12,500Indirect | Jun 10, 2026 | 5 |
| Hollingsworth Jane H | Director | 898 | Jun 10, 2026 | 1 |
| Gregoire Sylvie | Director, 10% Owner | 12,500Indirect | Jun 10, 2026 | 5 |
| Zavrl Frank | Director | – | Jun 10, 2026 | 1 |
| Poulton Jeffrey V. | Director | – | Jun 10, 2026 | 1 |
| Sabbagh Marwan | Director | – | Jun 10, 2026 | 1 |
| Quigley David | Director | – | Jun 10, 2026 | 2 |
| Blackburn Kelly | EVP, Clinical Development | – | Feb 13, 2026 | 1 |
| Elder William Robert | CFO, GC & Secretary | 12,500 | Feb 13, 2026 | 3 |
| De Rosch Mark | EVP, RA and GA and PgM | – | Feb 13, 2026 | 1 |
| Winton Matthew | Chief Commercial and Business | 15,000 | Feb 13, 2026 | 4 |
| Cobuzzi Robert Joseph Jr. | Chief Operating Officer | 1,616 | Feb 14, 2025 | 0 |
| Tanner John William | Chief Financial Officer | – | Jan 26, 2024 | 0 |
| Davidson Jill | Director | – | Sep 15, 2023 | 0 |
| Lanchoney Diana M | Director | 294 | Jul 5, 2023 | 0 |
| Jaeger Raven | Chief Regulatory Officer | – | Aug 26, 2022 | 0 |
| Hornung William Karl | Chief Financial Officer | – | Jan 31, 2022 | 0 |
| Galloway Christopher D | Chief Medical Officer | – | Jan 31, 2022 | 0 |
| Levin Alan G | Director | – | Jul 6, 2021 | 0 |
| Francois Eric | Director | – | Jul 6, 2021 | 0 |
| Adams Robert W | Director | – | Jul 6, 2021 | 0 |
| Giles Mark T | Director | – | Jul 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Boger Joshua SDirector, 10% Owner | PPurchase | +955.4K | $3.14 | +$3.00M | +113.7%1.80M after | |
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Boger Joshua SDirector, 10% Owner | PPurchase | +1.91M | – | – | –955.4K after | Derivative2 lots |
| Nov 19, 2025 (view filing) | Nov 17-18 | 2 days | Winton MatthewChief Commercial and Business | PPurchase | +5.00K | $8.29 | +$41.4K | +50.0%15.0K after | 2 lots |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +10.8K | $8.46 | +$91.3K | +0.7%1.48M after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +10.8K | $8.46 | +$91.4K | +638.3%12.5K after | |
| Nov 19, 2025 (view filing) | Nov 17-18 | 2 days | Elder William RobertCFO, GC & Secretary | PPurchase | +3.50K | $8.36 | +$29.3K | +38.9%12.5K after | 2 lots |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Alam John JCEO & President | PPurchase | +10.8K | $8.46 | +$91.4K | +0.7%1.48M after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Alam John JCEO & President | PPurchase | +10.8K | $8.46 | +$91.3K | +632.3%12.5K after | |
| Nov 17, 2025 (view filing) | Nov 13-14 | 4 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +6.15K | $7.53 | +$46.3K | +0.4%1.47M after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +1.69K | $7.55 | +$12.8K | New position1.69K after | |
| Nov 17, 2025 (view filing) | Nov 13-14 | 4 days | Alam John JCEO & President | PPurchase | +6.14K | $7.52 | +$46.2K | +0.4%1.47M after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Alam John JCEO & President | PPurchase | +1.71K | $7.57 | +$12.9K | New position1.71K after | |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Winton MatthewChief Commercial and Business | PPurchase | +10.0K | $7.57 | +$75.7K | New position10.0K after | |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Gregoire SylvieDirector, 10% Owner | PPurchase | +5.55K | $7.35 | +$40.8K | +0.4%1.47M after | |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Elder William RobertCFO, GC & Secretary | PPurchase | +3.50K | $7.44 | +$26.0K | +63.6%9.00K after | |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Alam John JCEO & President | PPurchase | +5.55K | $7.35 | +$40.8K | +0.4%1.47M after | |
| May 14, 2025 (view filing) | May 14 | Same day | Elder William RobertCFO, GC & Secretary | PPurchase | +4.23K | $8.46 | +$35.8K | +334.1%5.50K after | |
| Aug 27, 2024 (view filing) | Aug 27 | Same day | Elder William RobertCFO & GC | PPurchase | +1.00K | $18.16 | +$18.2K | +374.5%1.27K after | |
| Feb 28, 2024 (view filing) | Feb 26 | 2 days | Boger Joshua SDirector, 10% Owner | SSale | −36 | – | – | 0.0%840.5K after | |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Elder William RobertGC & Secretary | PPurchase | +5.00K | $0.50 | +$2.50K | –5.00K after | Derivative |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Cobuzzi Robert Joseph Jr.President & CEO | PPurchase | +5.00K | $0.50 | +$2.50K | –5.00K after | Derivative |